Pneumocystis carinii Mimicking Neonatal Lupus Erythematosus-Related Pneumonitis

Pediatric Dermatology

Volumn 20, Issue 6, 2003, Pages 524-528

  Wozniacka, Anna ^a   Robak, Ewa ^a   Sysa Jedrzejowska, Anna ^a   McCauliffe, Daniel P ^b,c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Rutland Skin Center   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATERNAL ANTIBODY;

ARTICLE; CASE REPORT; CLINICAL FEATURE; CONGENITAL HEART BLOCK; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOLOGIC DISEASE; HUMAN; INFANT; LABORATORY TEST; LIVER DISEASE; LUPUS ERYTHEMATOSUS; MALE; NEWBORN; PLACENTAL TRANSFER; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PRIORITY JOURNAL; SKIN DISEASE;

DIAGNOSIS, DIFFERENTIAL; HUMANS; INFANT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PNEUMOCYSTIS CARINII; PNEUMONIA, PNEUMOCYSTIS;

EID: 0346433973     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2003.20615.x     Document Type: Article

References (39)

1. Sontheimer RD, McCauliffe DP. Pathogenesis of anti Ro/SS-A autoantibody associated cutaneous lupus erythematosus. Dermatol Clin 1990;8:751-758.
2. Dugan EM, Tunnessen WW, Honig PJ, Watson RM. U1RNP antibody-positive neonatal lupus. Arch Dermatol 1992;128:1490-1494.
3. Miyagawa S, Kitamura W, Yoshioka J, Sakamoto K. Placental transfer of anticytoplasmic antibodies in annular erythema of newborns. Arch Dermatol 1981;117:569-572.
4. Viana VS, Nascimento JH, Elkon KB, Brot N, Campos de Carvalho AC, Bonfa E. Induction of in vitro heart block is not restricted to affinity purified anti-52 kDa Ro/SSA antibody from mothers of children with neonatal lupus. Lupus 1998;7:141-147.
5. Blaszczyk M, Rosinska-Borkowska D, Jarzabek-Chorzelska M, Niezurawska G, Konca I, Jablonska S. Neonatal lupus erythematosus. Przegl Dermatol 2000;3:207-216.
6. Weston WL, Morelli JG, Lee LA. The clinical spectrum of anti-Ro-positive cutaneous neonatal lupus erythematosus. J Am Acad Dermatol 1999;40:675-681.
7. McCauliffe DP. Neonatal lupus erythematosus. In: Harper J, Oranje A, Prose N, eds. Textbook of paediatric dermatology. Oxford: Blackwell Science, 2000.
8. Saxon A, Stiehm ER. The B-lymphocyte system. In: Stiehm ER, ed. Immunologic disorders in infants and children. Philadelphia: WB Saunders, 1989.
9. Buyon J, Roubey R, Swersky S, et al. Complete congenital heart block: risk of occurrence and therapeutic approach to prevention. J Rheumatol 1988;15:1104-1108.
10. Siren MK, Julkunen H, Kaaja R, Ekblad H, Koskimies S. Role of HLA in congenital heart block: susceptibility alleles in children. Lupus 1999;8:60-67.
11. Selander B, Cedergren S, Domanski H. A case of severe neonatal lupus erythematosus without cardiac or cutaneous involvement. Acta Pediatr 1998;1:105-107.
12. Watson RM, Lane AT, Barnett NK, Bias WB, Arnett FC, Provost TT. Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine 1984;63:362-378.
13. Bremers HH, Golitz LE, Weston WL, Hay WG. Neonatal lupus erythematosus. Cutis 1979;24:287-290.
14. Levy SB, Goldsmith LA, Morohashi M, Hashimoto K. Tubuloreticular inclusions in neonatal lupus erythematosus. JAMA 1976;235:2743-2744.
15. Fonseca E, Contreras F, Garcia-Frias E, Carrascosa MC. Neonatal lupus erythematosus with multisystem organ involvement preceding cutaneous lesions. Lupus 1991;1:49-50.
16. McCauliffe DP, Wang L, Satoh M, Reeves WH, Small D. A recombinant 52 kD Ro (SS-A) ELISA detects autoantibodies in Sjogren's syndrome sera that go undetected by conventional serologic assays. J Rheumatol 1997;24:860-866.
17. Crowley E, Frieden IJ. Neonatal lupus erythematosus: an unusual congenital presentation with cutaneous atrophy, erosions, alopecia and pancytopenia. Pediatr Dermatol 1998;15:38-42.
18. Ohtaki N, Miyamoto C, Orita M, Matsuo M. Concurrent multiple morphea and neonatal lupus erythematosus in an infant boy born to a mother with SLE. Br J Dermatol 1986;115:85-90.
19. Thornton CM, Eichenfield LF, Shinall EA, et al. Cutaneous telangiectases in neonatal lupus erythematosus. J Am Acad Dermatol 1995;33:19-25.
20. Alexander E, Buyon JP, Provost TT, Guarieri T. Anti-Ro/ SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome: an experimental model. Arthritis Rheum 1992;35:176-189.
21. Stephensen O, Cleland WP, Hallidie-Smith K. Congenital complete heart block and persistent ductus arteriosus associated with maternal systemic lupus erythematosus. Br Heart J 1981;46:104-106.
22. Houssiau FA, Lebacq EG. Neonatal lupus erythematosus with congenital heart block associated with maternal systemic lupus erythematosus. Clin Rheumatol 1986;5:505-508.
23. McCue CM, Mantakas ME, Tingelstad JB, Ruddy S. Congenital heart block in newborns of mothers with connective tissue disease. Circulation 1977;56:82-90.
24. Chameides L, Truex RC, Vetter V, Rashkind WJ, Galioto FM, Noonan JA. Association of maternal systemic lupus erythematosus with congenital complete heart block. N Engl J Med 1977;297:1204-1207.
25. Kosmetatos N, Blackman MS, Elrad H, Aubry RH. Congenital complete heart block in the infant of a woman with collagen vascular disease. A case report. J Reprod Med 1979;22:213-216.
26. Fox R, Hawkins DF. Fetal-pericardial effusion in association with congenital heart block and maternal systemic lupus erythematosus. Case report. Br J Obstet Gynecol 1990;97:638-640.
27. Ferrazzini G, Fasnacht M, Arbenz U, et al. Neonatal lupus erythematosus with congenital heart block and severe heart failure due to myocarditis and endocarditis of the mitral valve. Intensive Care Med 1996;22:464-466.
28. Provost TT, Watson R, Gaither KK, Harley JB. The neonatal lupus erythematosus syndrome. J Rheumatol 1987;14:199-205.
29. Lee LA, Sokol RJ, Buyon JP. Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry. Pediatrics 2002;109:E11.
30. Lee LA. Neonatal lupus erythematosus. J Invest Dermatol 1993;100:S9-S13.
31. McCauliffe DP, Sontheimer RD. Molecular characterization of the Ro/SS-A autoantigens. J Invest Dermatol 1993;100:S73-S79.
32. Lee LA, Frank MB, McCubbin VR, Reichlin M. Autoantibodies of neonatal lupus erythematosus. J Invest Dermatol 1994;102:963-966.
33. Silverman E, Mamula M, Hardin JA, Laxer R. Importance of immune response to the Ro/La particle in the development of congenital heart block and neonatal lupus erythematosus. J Rheumatol 1991;18:120-124.
34. Yukiko N. Immune responses to SS-A 52 and 60-kDa proteins and to SS-B 50-kDa protein in mothers of infants with neonatal lupus erythematosus. Br J Dermatol 2000;142:908-912.
35. Salomonsson S, Dorner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M. A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 2002;46:1233-1241.
36. Miranda-Carus ME, Boutjir M, Tseng CE, DiDonato F, Chan EK, Buyon JP. Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model. J Immunol 1998;161:5886-5892.
37. Tran HB, Macardle PJ, Hiscock J, et al. Anti-La/SSB antibodies transported across the placenta bind apoptotic cells targeted in fetal organs targeted in neonatal lupus. Arthritis Rheum 2002;46:1572-1579.
38. Provost TT, Watson R, O'Brien S. Anti-Ro (SS-A) antibody positive Sjögren/lupus erythematosus overlap syndrome. Lupus 1997;6:105-111.
39. Martin V, Lee LA, Askanase AD, Katholi M, Buyon JP. Long-term follow-up of children with neonatal lupus and their unaffected siblings. Arthritis Rheum 2002;46:2377-2383.